Nightingale (NN-1), named after Florence Nightingale the founder of modern nursing, is a poly hybrid indica bred from the legendary Shiskaberry and CD-1.
During testing, its CBD levels have ranged from 20.3% to 10.3%. The THC level varied the most out of all of the strains sold by Medical Marijuana Genetics, meaning this strain varied from between a 1:1 strain to a 20:1 strain. If you need fairly precise THC levels and do not have access to testing then beware of this strain. If you are looking for a high CBD, low THC strain and have access to a laboratory then this is one to test.
It is worth noting that from our research – and unlike its Candida parent - it appears that the indica phenotype that this plant produces is the 20:1 pheno, with the more sativa pheno producing a 1:1 strain.
Nightingale's berry lineage is evident in many of its characteristics, with striking purple leaves in flower, sweet berry aroma and high yield. It is perfect for night time use and can be utilised for those suffering with insomnia and anxiety, as well as a host of other medical conditions. Nightingale (NN-1) is suitable for all growing environments and is suitable for making extractions and vaping/smoking.
Nightingale (NN - 1) Feminised Seeds from Medical Marijuana Genetics
BREEDER/BRAND Medical Marijuana Genetics GENETICS Oldberry x CD-1 VARIETY Mostly Indica FLOWERING TYPE Photoperiod SEX Feminised THC CONTENT 0.68%-9% CBD CONTENT 10.3%-20.3% YIELD 300-500 gr/m2 GROWS Greenhouse, Indoors, Outdoors FLOWERING TIME 8-9 weeks MEDICAL CONDITIONS Fibromyalgia, Insomnia, Lupus, Multiple Sclerosis, Muscle Spasm, Nausea, Pain, Vomiting MEDICINAL PROPERTIES Chronic Pain, Muscle Spasms, Nausea, Vomiting, Fibromyalgia, Multiple Sclerosis, Lupus, Insomnia TASTE / FLAVOUR Berry, Sweet EFFECT Calming, Relaxing AWARDS 3rd place in CBD caterogy, Spannabis Champions Cup Madrid 2017